The protective effects of Omarigliptin against Lipopolysaccharide (LPS)- induced inflammatory response and expression of mucin 5AC (MUC5AC) in human bronchial epithelial cells
Authors:
- 1 January 2022
- journal article
- research article
- Published by Elsevier in Molecular Immunology
- Vol. 141, 108-115
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Oxidative stress–induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary diseaseJournal of Allergy and Clinical Immunology, 2015
- Neocryptotanshinone inhibits lipopolysaccharide-induced inflammation in RAW264.7 macrophages by suppression of NF-κB and iNOS signaling pathwaysActa Pharmaceutica Sinica B, 2015
- DPP‐4 Inhibitor Linagliptin Attenuates Aβ‐induced Cytotoxicity through Activation of AMPK in Neuronal CellsCNS Neuroscience & Therapeutics, 2015
- Resveratrol counteracts lipopolysaccharide-mediated microglial inflammation by modulating a SOCS-1 dependent signaling pathwayToxicology in Vitro, 2014
- The airway epithelium in asthmaNature Medicine, 2012
- Endogenous MCP-1 promotes lung inflammation induced by LPS and LTAMolecular Immunology, 2011
- Advances in Mucous Cell MetaplasiaAmerican Journal of Respiratory Cell and Molecular Biology, 2010
- Oxidative stress induces GLUT4 translocation by activation of PI3‐K/Akt and dual AMPK kinase in cardiac myocytesJournal of Cellular Physiology, 2007
- Superoxide Dismutases in the Lung and Human Lung DiseasesAmerican Journal of Respiratory and Critical Care Medicine, 2003
- Diabetes, oxidative stress, and antioxidants: A reviewJournal of Biochemical and Molecular Toxicology, 2003